Fighting river blindness and other ills.
D000969:Antinematodal Agents / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003140:Communicable Disease Control / Q000379:methods; D017281:Cost of Illness; D003906:Developing Countries; D014943:Global Health; D006801:Humans; D007559:Ivermectin / Q000627:therapeutic use; D018942:Macrolides / Q000627:therapeutic use; D015827:Onchocerciasis, Ocular / Q000453:epidemiology / Q000517:prevention & control*; D012109:Research Support as Topic; D014944:World Health Organization
D000969:Antinematodal Agents; D018942:Macrolides; D007559:Ivermectin; C027837:moxidectin